PHDA na Criança e Adolescente

Este endereço de email está protegido contra piratas. Necessita ativar o JavaScript para o visualizar.

Risco de lesões acidentais em crianças e adolescentes com PHDA e o impacto da medicação nesse risco: revisão sistemática e meta-análise

Artigo publicado pelos Drs. Maite Ruiz-Goikoetxea, Samuele Cortese, Maite Aznarez-Sanado, Sara Magallóne, Noelia Alvarez Zallo, Elkin O. Luis, Pilar de Castro-Manglano, Cesar Soutullo, Gonzalo Arrondo, no ResearchGate

Novembro 2017

Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication

Jangmo A¹, Stålhandske A², Chang Z³, Chen Q³, Almqvist C⁴, Feldman I⁵, Bulik CM⁶, Lichtenstein P³, D'Onofrio B⁷, Kuja-Halkola R³, Larsson H⁸.

1

Karolinska Institutet, Stockholm, Sweden. Electronic address: Este endereço de email está protegido contra piratas. Necessita ativar o JavaScript para o visualizar..

2

Karolinska Institutet, Stockholm, Sweden; Child and Adolescent Clinic, Stockholm County Council, Stockholm, Sweden.

3

Karolinska Institutet, Stockholm, Sweden.

4

Karolinska Institutet, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

5

Uppsala University, Uppsala, Sweden.

6

Karolinska Institutet, Stockholm, Sweden; University of North Carolina at Chapel Hill, NC.

7

Karolinska Institutet, Stockholm, Sweden; Indiana University, Bloomington, IN.

8

Karolinska Institutet, Stockholm, Sweden; School of Medical Sciences, Örebro University, Örebro, Sweden.

Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink

Tamsin Newlove-Delgado¹, William Hamilton¹, Tamsin J. Ford¹, Ken Stein², Obioha C. Ukoumunne².

1

University of Exeter Medical School, Exeter, UK

2

NIHR CLAHRC South West Peninsula [PenCLAHRC], University of Exeter Medical School, Exeter, UK

ADHD Attention Deficit and Hyperactivity Disorders

07/02/2019

Neurocognitive functioning in children with developmental dyslexia and attention-deficit/hyperactivity disorder: Multiple deficits and diagnostic accuracy

Artigo publicado pelos Drs. Octávio Moura,Marcelino Pereira,Cláudia Alfaiate,Eva Fernandes,Boavida Fernandes,Susana Nogueira,Joana Moreno &Mário R. Simões no Journal of Clinical and Experimental Neuropsychology

Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder—outcome measures beyond symptom control and clinical trials

Prof Ian C K Wong, PhD¹, Prof Tobias Banaschewski, MD², Prof Jan Buitelaar, MD³, Samuele Cortese, MD⁴, Döpfner Manfred Döpfner, PhD⁵, Prof Emily Simonoff, MD⁶, Prof David Coghill, MD⁷.
on behalf of the European ADHD Guidelines Group

1

Affiliations
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administrative Region, China
Research Department of Practice and Policy, University College London, School of Pharmacy, London, UK

2

Affiliations
Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany

3

Affiliations
Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, and Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, Netherlands

4

Affiliations
Centre for Innovation in Mental Health, School of Psychology and Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK

5

Affiliations
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Medical Faculty of the University of Cologne, Cologne, Germany

6

Affiliations
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, and National Institute for Health Research Maudsley Biomedical Research Centre for Mental Health, London, UK

7

Affiliations
Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Murdoch Children's Research Institute, Melbourne, VIC, Australia

The Lancet

Junho 2019

Risco de lesões acidentais em crianças e adolescentes com PHDA e o impacto da medicação nesse risco: revisão sistemática e meta-análise

Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication

Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink

Neurocognitive functioning in children with developmental dyslexia and attention-deficit/hyperactivity disorder: Multiple deficits and diagnostic accuracy

Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder—outcome measures beyond symptom control and clinical trials